SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009472
Filing Date
2022-05-12
Accepted
2022-05-12 08:01:45
Documents
42
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tcrx-20220331.htm   iXBRL 10-Q 2168071
2 EX-31.1 tcrx-ex31_1.htm EX-31.1 25912
3 EX-31.2 tcrx-ex31_2.htm EX-31.2 26185
4 EX-32.1 tcrx-ex32_1.htm EX-32.1 10644
5 EX-32.2 tcrx-ex32_2.htm EX-32.2 10536
  Complete submission text file 0000950170-22-009472.txt   5247640

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrx-20220331.xsd EX-101.SCH 35128
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcrx-20220331_def.xml EX-101.DEF 180688
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcrx-20220331_cal.xml EX-101.CAL 27318
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrx-20220331_lab.xml EX-101.LAB 329369
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrx-20220331_pre.xml EX-101.PRE 260924
36 EXTRACTED XBRL INSTANCE DOCUMENT tcrx-20220331_htm.xml XML 458826
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40603 | Film No.: 22915772
SIC: 2836 Biological Products, (No Diagnostic Substances)